In DLBCL, p53 is immunohistochemically detectable in 30 to 40% of cases, but only a fraction of p53+ DLBCL have an underlying mutation, thus p53 mutational status can obviously not be deduced from immunohistochemically detected p53 expression alone. Here, TP53 is linked to diffuse large B-cell lymphoma.